Literature DB >> 7513565

Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells.

Y Legros1, V Lacabanne, M F d'Agay, C J Larsen, M Pla, T Soussi.   

Abstract

We describe the production of 13 new monoclonal antibodies induced by the product of the human p53 tumor suppressor gene. All these monoclonal antibodies recognize human p53 irrespective of the detection technique: ELISA, immunoblot or immunoprecipitation. These antibodies can be divided into four groups according to such criteria as localization of the recognized epitopes and reactivity with p53 originating from other organisms. One monoclonal antibody was successfully used for immunohistochemistry detection of p53 accumulation in breast carcinoma. This novel panel of monoclonal antibodies represents a further tool for the study of the p53 protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7513565

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  9 in total

1.  Prognostic and Predictive Factors for Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

2.  Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Authors:  P Würl; H Taubert; A Meye; D Berger; C Lautenschläger; H J Holzhausen; H Schmidt; H Kalthoff; F W Rath; H Dralle
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Proteolysis by calpains: a possible contribution to degradation of p53.

Authors:  M Pariat; S Carillo; M Molinari; C Salvat; L Debüssche; L Bracco; J Milner; M Piechaczyk
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

4.  p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.

Authors:  A Puisieux; J Ji; C Guillot; Y Legros; T Soussi; K Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Detection of p73 antibodies in patients with various types of cancer: immunological characterization.

Authors:  O Tominaga; K Unsal; G Zalcman; T Soussi
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

6.  Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.

Authors:  F D Vogl; M Frey; R Kreienberg; I B Runnebaum
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

7.  Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.

Authors:  M Rusin; D Butkiewicz; E Malusecka; A Zborek; J Harasim; K Czyzewski; W P Bennett; P G Shields; A Weston; J A Welsh; S Krzyzowska-Gruca; M Chorazy; C C Harris
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

Authors:  K Ory; Y Legros; C Auguin; T Soussi
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

9.  Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

Authors:  B Schlichtholz; J Trédaniel; R Lubin; G Zalcman; A Hirsch; T Soussi
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.